I was waiting to buy some more at 22c, but dont think it will happen at that price. I think at some point in early 2021 the FOMO will start to kick in and this will rerate. At some point this will be sitting at $1+ and we'll all be thinking why didn't we buy more. I think NYE resolution is - top up on NYR.
$17M MC atm and realistically this should be sitting close to $100M or $200M pre-clinical trials. Once the clinical trials get underway in the latter half of 2021 and the positive results start to arrive (and all indications are good) then this could be pushing $1B+. Remember anti cholesterol drugs are money makers with huge market potential - hence why Novartis bought "The Medicine Company" (NASDAQ) for US$9.7B in January, just for its one and only anti-cholesterol drug (Inclisiran) that was still in phase 3 clinical trials. Another factor is that they are on track for a better product (oral rather than injection). Probably has the biggest potential on the ASX?
NYR Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)